$7 million gift to drive Mindgardens mood disorders researchMay 16, 2023
Businessman James Packer, with The Packer Family Foundation, has made a $7 million gift to establish the James Packer Chair in Mood Disorders at UNSW and the Mindgardens Neuroscience Network.
A/Prof Jackie Curtis appointed Director of MindgardensMay 16, 2023
Associate Professor Jackie Curtis MBBS FRANZCP has been appointed Director of Mindgardens Neuroscience Network (Mindgardens) commencing April 20th, 2020
KRC opens new clinic to provide healthcare to people who use drugsApril 27, 2023
The team from Population and Community Heath’s Kirketon Road Centre (KRC) has collaborated with Uniting to open a new free clinic in Kings Cross providing high quality, compassionate medical care to people who use drugs.
Australian first: Multicultural mindfulness for mental healthApril 27, 2023
In an Australian first, SESLHD’s Multicultural Health Service and the NSW Multicultural Health Communications Service have launched a new set of Multicultural Mindfulness Resources in seven languages.
Patients leaving hospital sometimes need opioids. Doctors can reduce risks of long-term use and dependenceApril 27, 2023
New national standards aim to change doctors' prescribing habits when patients with pain are discharged.
The vital role emergency departments play in frontline mental health careApril 27, 2023
Almost one in 10 young people aged 12 to 15 years old report ever having self-harmed and the leading cause of death in Australia for young people aged 15 to 24 years old is suicide.
Neuropsychology Tool Streamlines Cognitive Assessment, Diagnosis and CareApril 27, 2023
Currently, Australians can face delays of approximately 3 years on average between initial symptom presentation and a formal diagnosis of dementia.
Understanding Risk of Dementia and Alcohol ConsumptionApril 27, 2023
The review, published in Addiction, has shown that abstaining from alcohol completely can actually increase the risk of dementia.
Apathy may predict progression to dementiaApril 27, 2023
It is common amongst older people, affecting between 10-35% of people aged over 65.
World-first trial to investigate new medication for methamphetamine dependenceApril 27, 2023
Vivamus vitae libero et nulla laoreet placerat sit amet nec ante. In at lectus a arcu condimentum.
Brings together the strengths of four founding organisations